Julie Rubinstein sold $890K of Adaptive Biotechnologies (ADPT)

Executed Oct 14, disclosed Oct 16, 2 days later.

Value, as filed

$890K

35,343 sh across 4 lots

Executed

Oct 14

the trade date, as filed

Disclosed

Oct 16

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Julie Rubinstein President and COO profile →

Julie Rubinstein (President and COO) filed 23 Form 4 reports in the trailing twelve months (0 purchases, 23 sales), most often in Adaptive Biotechnologies Corporation (ADPT). The largest single filing was $2.3M of ADPT (174,303 sh across 4 lots, as filed), executed Mar 11.

The name

ADPT

Adaptive Biotechnologies Corporation ADPT · Healthcare · 80 filings in 24 months ticker →

Healthcare · Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of v…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Julie Rubinstein in ADPT

ADPTSALE Adaptive Biotechnologies Corporation $844K
31,662 sh across 5 lots
Exec Nov 4
Filed Nov 6 · 7:24 PM ET ADPTSALE Adaptive Biotechnologies Corporation $795K
30,663 sh across 3 lots
Exec Oct 30
Filed Nov 3 · 7:51 PM ET ADPTSALE Adaptive Biotechnologies Corporation $913K
32,443 sh across 3 lots
Exec Oct 27
Filed Oct 29 · 7:52 PM ET ADPTSALE Adaptive Biotechnologies Corporation $766K
30,565 sh across 4 lots
Exec Oct 22
Filed Oct 26 · 6:52 PM ET ADPTSALE Adaptive Biotechnologies Corporation $877K
35,543 sh across 4 lots
Exec Oct 19
Filed Oct 21 · 6:36 PM ET ADPTSALE Adaptive Biotechnologies Corporation $849K
32,943 sh across 3 lots
Exec Oct 9
Filed Oct 13 · 7:05 PM ET ADPTSALE Adaptive Biotechnologies Corporation $875K
33,143 sh across 3 lots
Exec Oct 6
Filed Oct 8 · 6:54 PM ET ADPTSALE Adaptive Biotechnologies Corporation $1.0M
35,643 sh across 5 lots
Exec Oct 1
Filed Oct 5 · 8:15 PM ET